King Welcomes Administration Implementing Prescription Drug Price Transparency Provision - InsuranceNewsNet

Get the magazine read by the nation’s top 1% of producers delivered to your door monthly. Subscribe Now

InsuranceNewsNet

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading newswires
Topics
  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property & Casualty
  • Advisor News
  • Washington Wire
  • Sponsored Content
  • INN Exclusives
  • Newswires
  • INNsider
  • INN Exclusives
  • NewsWires
  • Magazine
Sign in or register to be an INNsider.
  • INN Exclusives
  • NewsWires
  • ★ Regulation News
  • Magazine
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Susbcribe

Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Google+
Insider
newswires
newswires RSS Get our newsletter
Order Prints Share
May 9, 2019 newswires No comments Views: 32

King Welcomes Administration Implementing Prescription Drug Price Transparency Provision

Targeted News Service (Press Releases)

WASHINGTON, May 8 -- Sen. Angus S. King Jr., I-Maine, issued the following news release:

* * *

- HHS rule, finalized today, comes after King and colleagues led legislative push to require pharmaceutical companies to disclose prices in advertising

* * *

Today, U.S. Senator Angus King (I-Maine) applauded a move by the Administration to implement a piece of Senator King's bipartisan legislative efforts to require the disclosure of drug prices in advertising. The rule, first proposed by the Centers for Medicare and Medicaid and finalized today by the Department of Health and Human Services, reflects language from the King-backed Drug-Price Transparency in Communications Act and requires pharmaceutical companies to list prices in their prescription drugs in direct-to-consumer (DTC) advertisements. The rule will help to empower patients, promote transparency, and lower prescription drug costs.

"For decades, pharmaceutical companies have been able to advertise their drugs to the public without disclosing their prices, and all the while, those prices have continued to rise. No more," said Senator King. "This new rule, which has significant bipartisan support, will bring much-needed accountability and transparency to prescription drug costs, so patients can fully understand what they're being sold. This is an important step in the fight to provide real relief for American people struggling with the costs of prescription drugs, and I will continue pushing the Administration and my colleagues in Congress to enact additional changes to build on this important work."

Senator King's bipartisan work on this issue has attracted support from the AARP, American Medical Association, American Hospital Association, Federation of American Hospitals, America's Health Insurance Plans, BlueCross BlueShield Association, and the Campaign for Sustainable Rx Pricing. Senators King, Dick Durbin (D-Ill.) and Chuck Grassley (R-Iowa) advocated for the inclusion of an amendment based on the Drug-Price Transparency in Communications Act in the September 2018 "minibus" funding bill, but the provision was stripped from the final bill.

In 2017, the pharmaceutical industry spent more than $6 billion in DTC advertisements, which drive up health care costs by steering patients towards more expensive medications. The average American sees nine DTC prescription drug ads each day. Studies show that patients are more likely to ask their doctor for a specific brand-name medication, and doctors are more likely to prescribe one, when they have been marketed directly with drug advertisements. For these reasons, most countries have banned DTC prescription drug advertising, with the United States and New Zealand being the only two developed countries that allow it.

In addition to his support of the legislation mirroring this now-final rule, Senator King has supported a number of commonsense bills to drive down the costs of medication in the United States. In February, he joined a bipartisan group of colleagues to introduce legislation that would deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace - a proposal that would save consumers billions of dollars. In January, he cosponsored three bills to reduce the costs of prescription drugs. The first bill, the End Taxpayer Subsidies for Drug Ads Act, would prohibit pharmaceutical drug manufacturers from claiming tax deductions for consumer advertising expenses, and the Affordable and Safe Prescription Drug Importation Act would allow patients, pharmacists and wholesalers to import safe, affordable medicine from Canada and other major countries. The Empowering Medicare Seniors to Negotiate Drug Prices Act would allow for Medicare to negotiate the best possible price of prescription drugs to cut costs for nearly 43 million seniors enrolled in Medicare Part D. Current law only allows for bargaining by pharmaceutical companies and prohibits Medicare from doing so.

Older

Wild ride in Queens Midtown Tunnel leads to crash caught on dash cam

Newer

EPA Contributes More Than $97M To Improve Florida’s Water Infrastructure

Advisor News

  • Vanguard: Expect 2020 U.S. Economic Growth To Tail Off
  • Rep. Waters: House Passes Financial Services Bill Banning Insider Trading
  • Citi Outlook 2020: Global Growth Can Endure Over The Coming Year
  • LPL Financial Launches No-Transaction-Fee, Exchange-Traded Fund Network
  • 16 Year-End Financial Planning Tips From The AICPA
More Advisor News

Annuity News

  • Robert Kerzner Joins PHP Agency’s Board Of Directors
  • Patriot Life Insurance Co. Boosts Life & Annuities Underwriting Capabilities
  • Commentary: Ned Ryerson Is Just As Cool As Gordon Gekko
  • Industry, Consumer Reps Take Final Whack At NAIC Annuity Sales Rule
  • MassMutual Study Finds Employers Worried About Employees’ Financial Woes
More Annuity News

Health/Employee Benefits

  • Rising Prices Drive Up Health Spending, Even As Use Remains Steady
  • US Report: Prescription Drug Prices Down Slightly Last Year
  • Milliman Analysis: Corporate Pension Funding Rises By $15B In November
  • Poll: Most In U.S. Still Favor Private Healthcare, But Numbers Falling
  • Survey: Most Consumers Satisfied With Their Health Insurance
More Health/Employee Benefits

Life Insurance

  • Pacific Life Sells Aviation Capital Group To Tokyo Century Corp.
  • Robert Kerzner Joins PHP Agency’s Board Of Directors
  • Florida Man Convicted Of Murdering Wife For Life Insurance
  • LIMRA: 3Q Life Insurance Sales Driven By 7% Bump In IUL
  • Foresters Financial Updates Underwriting To Cover Pot Smokers
More Life Insurance

Featured Offers

Text Ads

Press ReleasesAll press releases

  • Brookstone Capital Management Expands Darryl Ronconi’s Role, Naming Him President and Chief Operating Officer
  • WoodmenLife Launches Unified Selling Experience for Agents with iPipeline
  • National Western Life Selects Equisoft to Accelerate its Growth Strategy
  • Peter M. Bakker Agency awarded first Insurance Agency Apprenticeship in the State of Connecticut
  • iPipeline’s New Global Website Features Extensive SSG Digital Platform Offering
Add your Press Release >

Topics

  • Life Insurance
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty News
  • Advisor News
  • Washington Wire
  • Regulation

Top Sections

  • INN Exclusives
  • INN Insider

Our Company

  • About
  • Editorial Staff
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter Google+
© 2019 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • Sitemap
  • AdvisorNews

Sign in with your INNsider Account

Not registered? Become an INNsider.